A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer

C. Forbes; J. Wilby; G. Richardson; M. Sculpher; L. Mather; R. Riemsma

doi:10.3310/hta6230

A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer

Health Technology Assessment ◽

10.3310/hta6230 ◽

2002 ◽

Vol 6 (23) ◽

Cited By ~ 11

Author(s):

C. Forbes ◽

J. Wilby ◽

G. Richardson ◽

M. Sculpher ◽

L. Mather ◽

...

Keyword(s):

Systematic Review ◽

Ovarian Cancer ◽

Economic Evaluation ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Doxorubicin Hydrochloride

Download Full-text

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation

Health Technology Assessment ◽

10.3310/hta10090 ◽

2006 ◽

Vol 10 (9) ◽

Cited By ~ 26

Author(s):

C Main ◽

L Bojke ◽

S Griffin ◽

G Norman ◽

M Barbieri ◽

...

Keyword(s):

Systematic Review ◽

Ovarian Cancer ◽

Economic Evaluation ◽

Liposomal Doxorubicin ◽

Advanced Ovarian Cancer ◽

Pegylated Liposomal Doxorubicin ◽

Subsequent Treatment ◽

Second Line ◽

Doxorubicin Hydrochloride

Download Full-text

Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum‐Sensitive Recurrent Ovarian Cancer: A Systematic Review

The Oncologist ◽

10.1634/theoncologist.2009-0331 ◽

2010 ◽

Vol 15 (10) ◽

pp. 1073-1082 ◽

Cited By ~ 9

Author(s):

Robert W. Holloway ◽

Edward C. Grendys ◽

Patrick Lefebvre ◽

Francis Vekeman ◽

Scott McMeekin

Keyword(s):

Systematic Review ◽

Ovarian Cancer ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer ◽

Efficacy And Safety ◽

Platinum Sensitive

Download Full-text

8050 POSTER Cost-effectiveness of Trabectedin in Combination With Pegylated Liposomal Doxorubicin Hydrochloride for the Treatment of Women With Relapsed Platinum-sensitive Ovarian Cancer in the UK -Analysis Based on the Final Survival Data

European Journal of Cancer ◽

10.1016/s0959-8049(11)72138-4 ◽

2011 ◽

Vol 47 ◽

pp. S542 ◽

Cited By ~ 2

Author(s):

M. Gore ◽

I. Vergote ◽

S. Vasanthan ◽

S. Chan ◽

J.M. Arranz ◽

...

Keyword(s):

Ovarian Cancer ◽

Cost Effectiveness ◽

Survival Data ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Doxorubicin Hydrochloride ◽

Platinum Sensitive ◽

Final Survival ◽

The Uk

Download Full-text

Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain

British Journal of Cancer ◽

10.1038/sj.bjc.6601228 ◽

2003 ◽

Vol 89 (6) ◽

pp. 1002-1007 ◽

Cited By ~ 24

Author(s):

B Ojeda ◽

L M de Sande ◽

A Casado ◽

P Merino ◽

M A Casado

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Doxorubicin Hydrochloride ◽

Cost Minimisation Analysis ◽

Cost Minimisation

Download Full-text

PCN212 ECONOMIC EVALUATION OF TOPOTECAN IN COMPARISON WITH PEGYLATED LIPOSOMAL DOXORUBICIN IN THE TREATMENT OF RECURRENT OVARIAN CANCER IN IRAN

Value in Health ◽

10.1016/j.jval.2019.09.408 ◽

2019 ◽

Vol 22 ◽

pp. S477

Author(s):

S. Sheikhi ◽

S. Taheri ◽

N. Shobeiri ◽

F. Peiravian

Keyword(s):

Ovarian Cancer ◽

Economic Evaluation ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer

Download Full-text

PCN23 Cost-Effectiveness Analysis of Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, and paclitaxel As Second-LINE Chemotherapy in the Treatment of Platinum-Resistant Ovarian Cancer in Iran

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.073 ◽

2020 ◽

Vol 22 ◽

pp. S8

Author(s):

N. Shobeiri

Keyword(s):

Ovarian Cancer ◽

Cost Effectiveness ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Cost Effectiveness Analysis ◽

Second Line ◽

Doxorubicin Hydrochloride ◽

Second Line Chemotherapy ◽

Effectiveness Analysis ◽

Line Chemotherapy

Download Full-text

Targeting Carbonic Anhydrase IX Enhances the Cellular Uptake and Cytotoxicity of PEGylated Liposomal Doxorubicin in Ovarian Cancer Cells

10.26226/morressier.57d6b2b9d462b8028d88d9ef ◽

2016 ◽

Author(s):

Ahmed Shabana

Keyword(s):

Ovarian Cancer ◽

Carbonic Anhydrase ◽

Cancer Cells ◽

Cellular Uptake ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Carbonic Anhydrase Ix ◽

Ovarian Cancer Cells

Download Full-text

Faculty Opinions recommendation of Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4324967.793485311 ◽

2013 ◽

Author(s):

Maurie Markman

Keyword(s):

Ovarian Cancer ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Late Relapse ◽

Platinum Sensitive

Download Full-text

Faculty Opinions recommendation of Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718028212.793483427 ◽

2013 ◽

Author(s):

Roberto Angioli

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin

Download Full-text

Faculty Opinions recommendation of PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718144304.793486590 ◽

2013 ◽

Author(s):

Roberto Angioli

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Platinum Resistant ◽

Randomized Phase Ii

Download Full-text